ReviewDer Nervenarzt2026
[ADHS in transition: how can continuity in treatment succeed?]
Review in Der Nervenarzt, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe transition from child and adolescent to adult psychiatric care constitutes a high-risk period for young people with attention deficit hyperactivity disorders (ADHD). Differences in healthcare service structures, therapeutic concepts and responsibility allocation frequently result in discontinuity and termination of treatment.
aimTo summarize key challenges of ADHD transition and derive practice-oriented recommendations to improve continuity of care. MATERIAL AND
methodsNarrative review of current guidelines (AWMF, NICE), relevant empirical literature and qualitative studies addressing patient, family and clinician perspectives.
resultsMajor barriers include limited patient knowledge of ADHD, marked organizational difficulties, insufficient intersectoral coordination, lack of awareness of adult services and regional shortages of specialized ADHD care. Divergent treatment cultures and the abrupt reduction of parental involvement further complicate the process. DISCUSSION: The ADHD is a persistent neurodevelopmental disorder requiring age-spanning, continuous care. Effective transition depends on structured procedures, reliable communication between services, developmentally adjusted family involvement and specialized treatment options. Future models should integrate developmental and autonomy-focused approaches from pediatric, juvenile and adult psychiatry.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.